Eli Lilly and Company (NYSE: LLY), a United States-based pharmaceutical company, announced on Wednesday that its board of directors has approved a dividend for the fourth quarter of 2023.
The dividend of USD1.13 per share on outstanding common stock is payable to shareholders of record at 15 November 2023 on 8 December 2023.
Perrigo announces quarterly dividend
Valneva receives CEPI funding to boost access to world's first chikungunya vaccine
CVS Health announces quarterly dividend
Emmaus Life Sciences reports 2023 financial results
Quest Diagnostics to acquire LifeLabs from OMERS for USD1.35bn
Eli Lilly announces Q3 2024 dividend
Valneva's chikungunya vaccine IXCHIQ approved by Health Canada
AbbVie announces quarterly cash dividend
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline